Injectable Steroids

Cypilos 250 mg Driada Medical

Driada Medical

55,00

In Stock (100 available)

Cypilos 250 mg Driada Medical (250 mg) — This Driada Medical formulation delivers this pharmaceutical-grade injectable compound is formulated for optimal bioavailability t…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

Testosterone Cypionate, Driada Medical, 250 mg. Eight-day ester; once-weekly injection is the typical schedule, twice-weekly for tighter dose control. Interchangeable with enanthate in almost every cycle design. Clinically documented across decades of TRT use.

Key Benefits

  • Functionally equivalent to testosterone enanthate at the receptor level
  • Slightly longer ester — weekly pinning produces flatter plasma curves
  • US-market standard for TRT and performance use
  • Full aromatisation — AI on hand from day one
  • Foundation compound for every common stack protocol
  • Each unit dosed at 250 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: TRT 100–200 mg/week; first cycle 400–500 mg/week; intermediate 500–600 mg/week; advanced 700+ mg/week. Split across 2 injections per week even though once-weekly is pharmacokinetically acceptable — flatter plasma smooths E2 management.

How It Works

Testosterone esterified to cyclopentanepropionic acid. Plasma esterases cleave the ester, releasing free testosterone to bind the AR across muscle, bone, and CNS. Functionally identical to enanthate in biological activity; ester difference affects only release kinetics.

Pharmacokinetics

Plasma half-life approximately 8 days. Once-weekly acceptable but produces a ~2× peak-trough swing; twice-weekly preferred. Steady-state at week 4–6. Clearance slower than enanthate — PCT begins 14 days after last pin.

Potential Side Effects

Standard testosterone side-effect profile: oestrogenic (manageable with AI), androgenic (genotype-dependent), HPTA suppression (universal). Hematocrit rise common above 500 mg/week — pull CBC mid-cycle.

Cycle & Stacking Guide

Cycle base, 12–16 weeks. Stack as with enanthate: deca/anadrol (mass), primobolan/boldenone (lean-gain), trenbolone/masteron (cutting). PCT at day 14 post-last-injection with Clomid 50mg + Nolva 20mg for 4 weeks.

Manufacturer Notes

Driada Medical positions itself at the affordable end of the market while maintaining third-party lab verification. Their vial caps carry a tamper-seal date code.

Storage & Handling

Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Cypilos 250 mg Driada Medical”

Your email address will not be published. Required fields are marked *